← All funding rounds

Tolremo raises €4.7M Series A round

9 June 2020· Basel, Switzerland· health, biotech, drug_discovery, oncology, small_molecule_therapeutics, epigenetics, b2b

Additional capital for ongoing operations and development.

About Tolremo

Stage

Series A

Headquarters

Basel, Switzerland

Founded

2017

Team Size

6–20

Sectors

healthbiotechdrug_discoveryoncologysmall_molecule_therapeuticsepigeneticsb2b

https://www.tolremo.com/

Source: https://www.top100startup.ch/en/startups/tolremo-therapeutics-ag